• Anti-Tau [pS199]
(Polyclonal) Antibody
Anti-Tau phosphorylated at serine 199- Polyclonal Antibody
Product Specifications
Research Area Neuroscience
Host Species Rabbit
Reactive Species Human,Mouse,Rat
Target Tau [pS199]
Tested Applications WB,IHC,IF
Clonality Polyclonal
Conjuation Label Unconjugated
Sample Types Cells,Tissues
Physical Format Liquid Form
Shipping Conditions Room Temperature
Storage Conditions (-)20 deg.C
Storage Buffer Glycerol
Formulation Rabbit serum diluted in glycerol with 0.05% sodium azide.
Regulatory Information RUO
Technical Notes WB : 1:4000 in Tris HCl pH 8.0, Tween 20 0.05% and 5% dry skimmed milk (working with cells and tissues) IHC: 1:200 in PBS with 5% BSA (working with cells, tissue sections (frozen and parrafin embedded) (concentrations may be adjusted according sample types)
Application Notes Obtained by immunizing a rabbit with a 12 amino acid peptide containing the phosphorylated serine 199 (SGYSSPGSPGT). The phosphorylated threonine is underlined.
Application Tau proteins are encoded by a single gene MAPT (Gene ID: 4137). They belong to the family of microtubule-associated proteins. Neurofibrillary degeneration is characterized by an accumulation of fibrils made of hyper and abnormally phosphorylated Tau proteins. The Tau phosphorylation at serine 199 is an indicator of the early step of neurofibrillary degeneration. On human brain tissue or in animal models of tauopathies, this antibody detects specifically neurons in neurofibrillary degeneration. The serine 199 is phosphorylated by the following kinases: CDK5 (cyclin dependent kinase 5), CK2 (casein kinase 2), PKA (protein kinase A), GSK3 (glycogen synthase kinase 3), ERK/MAPK (mitogen activated kinases) and MARK (Microtubule-associated protein/microtubule affinity-regulating kinase).
Articles & Publications Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D and Buee L (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THY-Tau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res. 9(4):397-405. Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E , Schraen-Maschke S, and Buee L (2008) Biochemistry of Tau in Alzheimer’s disease and related neurological disorders. Expert review of proteomics 5: 207–224. Sergeant N, Vingtdeux V, Eddarkaoui S, Gay M, Evrard C, Le Fur N, Laurent C, Caillierez R, Obriot H, Larchanché PE, Farce A, Coevoet M, Carato P, Kouach M, Descat A, Dallemagne P, Buée-Scherrer V, Blum D, Hamdane M, Buée L, Melnyk P. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer’s disease. Neurobiol Dis. 2019 Sep;129:217-233.

Note: You will be required to log into your account to send us this request.


Write a review

Please login or register to review

Anti-Tau [pS199] (Polyclonal) Antibody

  • Brand: 4BioDx
  • Product Code: 4BioDx-4BDX-1502
  • Availability: Pre-Order

Available Options


Tags: Tau, Amyloid